Physician profile
Andre P Desire
NPI 1568427714
$4,614.70
in general payments reported to CMS, 2019-2025
28 companies · $817 in 2025
The $817 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $648 · 2021: $690 · 2022: $635 · 2023: $543 · 2024: $736 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $868.34 | 2020-2025 | |
| Edwards Lifesciences Corporation | $839.25 | 2020-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $477.60 | 2020-2025 | Camzyos, Eliquis, Coumadin |
| Medtronic, INC. | $259.94 | 2023-2025 | Onyx Frontier, Endurant Iis, Hawkone |
| Bard Peripheral Vascular, INC. | $243.44 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.47 | 2019-2022 | |
| Pfizer INC. | $183.48 | 2019-2023 | |
| Amgen INC. | $165.65 | 2019-2025 | |
| Heartflow, INC. | $153.72 | 2020-2022 | |
| Scpharmaceuticals INC. | $133.38 | 2025 | |
| Inari Medical, INC. | $131.28 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $126.07 | 2022-2024 | Gallant, Cardiomems |
| W. L. Gore & Associates, INC. | $120.64 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Philips North America LLC | $110.45 | 2022 | |
| Abiomed | $83.80 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $72.44 | 2019 | |
| Stryker Corporation | $62.32 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Janssen Pharmaceuticals, INC | $58.79 | 2019-2021 | |
| Astellas Pharma US INC | $50.84 | 2021-2022 | |
| Novo Nordisk INC | $41.46 | 2024 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $33.01 | 2025 | Comet |
| Cvrx, INC. | $32.98 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $29.18 | 2023 | Arcalyst |
| Bolton Medical INC | $29.16 | 2025 | Treo Abdominal Stent-Graft System |
| Spectrawave, INC | $22.86 | 2024 | Starlight Imaging Catheter, Hypervue Imaging System |
| Baxter Healthcare | $19.76 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $16.21 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Desire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.